|
GOPC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.812840E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.537600E-02 |
| Normal-vs-Stage2 |
7.306200E-01 |
| Normal-vs-Stage3 |
7.274000E-01 |
| Normal-vs-Stage4 |
7.420200E-01 |
| Stage1-vs-Stage2 |
4.935200E-01 |
| Stage1-vs-Stage3 |
3.755200E-01 |
| Stage1-vs-Stage4 |
6.216000E-01 |
| Stage2-vs-Stage3 |
9.514400E-01 |
| Stage2-vs-Stage4 |
9.823400E-01 |
| Stage3-vs-Stage4 |
9.379200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.766440E-01 |
| Normal-vs-AfricanAmerican |
4.062200E-01 |
| Normal-vs-Asian |
5.239800E-01 |
| Caucasian-vs-AfricanAmerican |
8.726200E-01 |
| Caucasian-vs-Asian |
9.758600E-01 |
| AfricanAmerican-vs-Asian |
9.784000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.130400E-02 |
| Normal-vs-Female |
4.265400E-01 |
| Male-vs-Female |
1.741720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.376400E-02 |
| Normal-vs-Extreme_Weight |
5.359400E-03 |
| Normal-vs-Obese |
6.622000E-01 |
| Normal-vs-Extreme_Obese |
2.112000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.754200E-01 |
| Normal_Weight-vs-Obese |
7.678400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.359800E-01 |
| Extreme_Weight-vs-Obese |
9.084400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.878400E-01 |
| Obese-vs-Extreme_Obese |
2.005200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.534600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.038400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.724010E-02 |
| Normal-vs-Age(81-100Yrs) |
2.517900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.260200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.022000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.771850E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.172410E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.608400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.711800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.899000E-01 |
| Normal-VS-Type2 PRCC |
1.557760E-03 |
| Normal-VS-KIRP CIMP |
2.179600E-01 |
| Normal-VS-Unclassified PRCC |
6.391800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.376100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.026010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.758400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.420200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.037180E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.584440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.367100E-04 |
| Normal-vs-N1 |
1.528970E-01 |
| Normal-vs-N2 |
1.114420E-02 |
| N0-vs-N1 |
1.604390E-03 |
| N0-vs-N2 |
5.774600E-01 |
| N1-vs-N2 |
7.097600E-02 |
|
|
